FDA Pediatric Study Bill Clears Senate, Will Sunset With Exclusivity Grants

Legislation restoring FDA's authority to require drug sponsors to conduct trials in children would sunset at the same time as the pediatric exclusivity incentive program under a bill adopted by the Senate July 23